Depression Medicines | FDA - U.S. Food and Drug Administration
Use the following information to help you talk to your healthcare provider about medicines called antidepressants that can help treat depression. The medicine charts list FDA-approved …
Depression | FDA - U.S. Food and Drug Administration
Jul 10, 2024 · Depression is one of the most common mental disorders in the United States. Depression does not discriminate, and can affect anyone regardless of age, race, ethnicity, or …
FDA clears first digital treatment for depression, but experts ... - CNN
Apr 2, 2024 · The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder.
Women and Depression - FDA
Aug 10, 2023 · FDA information on signs of depression, treatment and depression and pregnancy.
FDA approves 'ketamine' nasal spray for depression - MSN
For the first time, the U.S. Food and Drug Administration (FDA) has approved the use of a ketamine-like drug as a stand-alone therapy for adults with treatment-resistant depression …
FDA approves standalone use of J&J’s ketamine-derived depression ...
Jan 22, 2025 · The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients …
FDA-Approved Nasal Spray For Depression Is First Of Its Kind
Jan 24, 2025 · A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & …
FDA approves first-of-its-kind nasal spray for severe depression
Jan 22, 2025 · Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive …
Spravato Nasal Spray Can Now Be Used Alone for Treatment …
Jan 28, 2025 · The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with …
Major depression: FDA approves esketamine nasal spray
Jan 27, 2025 · The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in people who have not responded to at least …
- Some results have been removed